Download PDF
CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2022; 31(02): e82-e92
DOI: 10.1055/s-0042-1743205
Artículo de Revisión | Review Article
Andrology, Sexuality, and Reproduction / Andrología, Sexualidad y Reproducción

Disfunción eréctil en personas con VIH – Revisión de alcance

Erectile Dysfunction in People with HIV – A Scoping Review
Isabella Lince-Rivera 
1   Pontificia Universidad Javeriana, Bogotá, Colombia
2   Universidad Militar Nueva Granada, Bogotá, Colombia
,
Mauricio Medina-Rico 
1   Pontificia Universidad Javeriana, Bogotá, Colombia
,
Eduardo Nuñez-Rodriguez 
1   Pontificia Universidad Javeriana, Bogotá, Colombia
,
Mónica Maria Medina F. 
1   Pontificia Universidad Javeriana, Bogotá, Colombia
2   Universidad Militar Nueva Granada, Bogotá, Colombia
,
Hugo López-Ramos 
1   Pontificia Universidad Javeriana, Bogotá, Colombia
3   Unidad de Urología, Hospital Universitario San Ignacio, Bogotá, Colombia
› Author Affiliations
› Further Information
   Permissions and Reprints

Resumen

Objetivo Exponer los factores que han sido asociados al desarrollo de disfunción eréctil (DE) en las personas con virus de la inmunodeficiencia humana (VIH) y cuál es la prevalencia de la disfunción eréctil en esta población.

Métodos Se realizó una revisión de alcance utilizando las siguientes bases de datos: MEDLINE, CENTRAL, Embase, Scopus, Lilacs, y Psycinfo. Los artículos incluidos debían tener cualquier información relacionada con la DE en personas con VIH, su prevalencia, y posibles factores asociados. Se filtraron un total de 2.726 artículos por título y resumen, y, de estos, se seleccionaron 22 referencias para revisión de texto completo y análisis.

Resultados Se encontró que las personas con VIH tienen una mayor probabilidad de presentar DE en comparación con las personas sin VIH. Algunos estudios han establecido una asociación entre la DE y trastornos psicológicos o factores orgánicos, como la lipodistrofia, la hipertensión arterial, la hipercolesterolemia, la diabetes mellitus, la depresión, la ansiedad, y el hipogonadismo. La ingesta de terapia antirretroviral (TARV), más específicamente los inhibidores de la proteasa, sigue siendo cuestionada como causante de DE en pacientes con VIH.

Conclusiones Ante un paciente con diagnóstico de VIH, se debe ahondar sobre DE con el fin de recomendar e iniciar conductas terapéuticas que aseguren un mejoramiento en su calidad de vida.

Abstract

Aim To present factors that have been associated with the development of erectile dysfunction (ED) in people with human immunodeficiency virus (HIV) and the frequency of erectile dysfunction among this population.

Methods We performed a scoping review on the following databases: MEDLINE, CENTRAL, Embase, Scopus, Lilacs, and Psycinfo. The articles included information related to ED in people with HIV, its frequency, and possible associated factors. A total of 2,726 articles were filtered by title and abstract, and, from these, 22 references were selected for full-text review and analysis.

Results People with HIV were found to be more likely to have ED compared to people without HIV. Some studies have established an association between ED and psychological disorders or organic factors, such as lipodystrophy, high blood pressure, hypercholesterolemia, diabetes mellitus, depression, anxiety, and hypogonadism. The intake of antiretroviral therapy (ART), more specifically protease inhibitors, continues to be questioned as a cause of ED in patients with HIV.

Conclusions In HIV-positive men, we recommend to actively seek ED in order to initiate therapeutic conducts that can ensure an improvement in their quality of life.

Palabras Clave

VIH - SIDA - disfunción eréctil - disfunción sexual - conducta sexual - calidad de vida

Keywords

HIV - AIDS - erectile dysfunction - sexual dysfunction - sexual behavior - quality of life


Publication History

Received: 08 March 2021

Accepted: 08 August 2021

Article published online:
21 June 2022

© 2022. Sociedad Colombiana de Urología. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • Referencias

  • 1 Parra A, Silva HJM, Estupiñan N. et al. Prevalencia y posible etiología de la disfunción eréctil en pacientes VIH positivos del Hospital Universitario San Ignacio. Rev Urol Colomb 2012; XXI (01) 32-39
    PubMedGoogle Scholar
  • 2 Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI. et al. Erectile dysfunction among hiv patients undergoing highly active antiretroviral therapy: Dyslipidemia as a main risk factor. Sex Med 2014; 2 (01) 24-30
    CrossrefPubMedGoogle Scholar
  • 3 Naciones Unidas. Monitoreo Global de SIDA 2021. Indicadores para el seguimiento de la Declaración Política de las Naciones Unidas para poner fin al SIDA de 2016. 2020: 214 . Available from: http://www.unaids.org/sites/default/files/media_asset/global-aids-monitoring_es.pdf
    PubMedGoogle Scholar
  • 4 Lin X, Mattson CL, Freedman M, Skarbinski J. Medical Monitoring Project. Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who have Sex with Men in the United States. AIDS Behav 2017; 21 (04) 1129-1137 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988354340&doi=10.1007%2Fs10461-016-1552-1&partnerID=40&md5=5d867999bca14b6cd6aaba84df73708c [Internet]
    CrossrefPubMedGoogle Scholar
  • 5 Luo L, Deng T, Zhao S. et al. Association Between HIV Infection and Prevalence of Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med 2017; 14 (09) 1125-1132
    CrossrefPubMedGoogle Scholar
  • 6 Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z. (Editors) JBI Manual for Evidence Synthesis, JBI, 2020. Available from https://synthesismanual.jbi.global. DOI: 10.46658/JBIMES-20-12
    CrossrefGoogle Scholar
  • 7 Wang Q, Young J, Bernasconi E. et al; Swiss HIV Cohort Study. The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antivir Ther 2013; 18 (03) 337-344
    CrossrefPubMedGoogle Scholar
  • 8 Hart TA, Moskowitz D, Cox C. et al. The cumulative effects of medication use, drug use, and smoking on erectile dysfunction among men who have sex with men. J Sex Med 2012; 9 (04) 1106-1113
    CrossrefPubMedGoogle Scholar
  • 9 Fumaz CR, Ayestaran A, Perez-Alvarez N. et al. Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men. Am J Men Health 2017; 11 (03) 647-653
    CrossrefPubMedGoogle Scholar
  • 10 Bouhlel S, Derbel CH, Nakhli J. et al. Sexual dysfunction in Tunisian patients living with HIV. Sexologies 2017; 26 (02) e11-e16
    CrossrefPubMedGoogle Scholar
  • 11 Ende AR, Lo Re III V, DiNubile MJ, Mounzer K. Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care STDS 2006; 20 (02) 75-78
    CrossrefPubMedGoogle Scholar
  • 12 Crum-Cianflone NF, Bavaro M, Hale B. et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007; 21 (01) 9-19
    CrossrefPubMedGoogle Scholar
  • 13 Pérez I, Moreno T, Navarro F, Santos J, Palacios R. Prevalence and factors associated with erectile dysfunction in a cohort of HIV-infected patients. Int J STD AIDS 2013; 24 (09) 712-715 http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L370229500 [Internet]
    CrossrefPubMedGoogle Scholar
  • 14 Enoma A, Ching SM, Hoo FK, Omar SFS. Prevalence and factors associated with erectile dysfunction in male patients with human immunodeficiency virus in a teaching hospital in West Malaysia. Med J Malaysia 2017; 72 (03) 186-189 http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L617507766%0Ahttp://vu.on.worldcat.org/atoztitles/link?sid=EMBASE&issn=03005283&id=doi:&atitle=Prevalence+and+factors+associated+with+erectile+dysfunction+in+male+patients+with+human [Internet]
    PubMedGoogle Scholar
  • 15 Shindel AW, Horberg MA, Smith JF, Breyer BN. Sexual dysfunction, HIV, and AIDS in men who have sex with men. AIDS Patient Care STDS 2011; 25 (06) 341-349
    CrossrefPubMedGoogle Scholar
  • 16 Zona S, Guaraldi G, Luzi K. et al. Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. J Sex Med 2012; 9 (07) 1923-1930
    CrossrefPubMedGoogle Scholar
  • 17 Richardson D, Lamba H, Goldmeier D, Nalabanda A, Harris JRW. Factors associated with sexual dysfunction in men with HIV infection. Int J STD AIDS 2006; 17 (11) 764-767
    CrossrefPubMedGoogle Scholar
  • 18 Cove J, Petrak J. Factors associated with sexual problems in HIV-positive gay men. Int J STD AIDS 2004; 15 (11) 732-736
    CrossrefPubMedGoogle Scholar
  • 19 Dijkstra M, van Lunsen RHW, Kooij KW, et al. HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy. AIDS 2018;32(9):1137–1146
    PubMed
  • 20 Asboe D, Catalan J, Mandalia S. et al. Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care 2007; 19 (08) 955-965
    CrossrefPubMedGoogle Scholar
  • 21 Adebimpe WO, Omobuwa O, Adeoye OA. Prevalence and predictors of erectile dysfunctions among men on antiretroviral therapy in South-Western Nigeria. Ann Med Health Sci Res 2015; 5 (04) 279-283
    CrossrefPubMedGoogle Scholar
  • 22 Schrooten W, Colebunders R, Youle M. et al; Eurosupport Study Group. Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS 2001; 15 (08) 1019-1023
    CrossrefPubMedGoogle Scholar
  • 23 Lallemand F, Salhi Y, Linard F, Giami A, Rozenbaum W. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr 2002; 30 (02) 187-190
    CrossrefPubMedGoogle Scholar
  • 24 Lamba H, Goldmeier D, Mackie NE, Scullard G. Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. Int J STD AIDS 2004; 15 (04) 234-237
    CrossrefPubMedGoogle Scholar
  • 25 De Ryck I, Van Laeken D, Apers L, Colebunders R. Erectile dysfunction, testosterone deficiency, and risk of coronary heart disease in a cohort of men living with HIV in Belgium. J Sex Med 2013; 10 (07) 1816-1822
    CrossrefPubMedGoogle Scholar
  • 26 Guaraldi G, Luzi K, Murri R. et al. Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. Antivir Ther 2007; 12 (07) 1059-1065
    CrossrefPubMedGoogle Scholar
  • 27 Rajiah K, Veettil KS, Kumar S, Mathew EM. Psychological impotence: Psychological erectile dysfunction and erectile dysfunction causes, diagnostic methods and management options. Sci Res Essays 2012;7(4):446–452
    PubMed
  • 28 Nguyen HMT, Gabrielson AT, Hellstrom WJG. Erectile Dysfunction in Young Men-A Review of the Prevalence and Risk Factors. Sex Med Rev 2017; 5 (04) 508-520 DOI: 10.1016/j.sxmr.2017.05.004. [Internet]
    CrossrefPubMedGoogle Scholar
  • 29 Liu Q, Zhang Y, Wang J. et al. Erectile Dysfunction and Depression: A Systematic Review and Meta-Analysis. J Sex Med 2018; 15 (08) 1073-1082 DOI: 10.1016/j.jsxm.2018.05.016. [Internet]
    CrossrefPubMedGoogle Scholar
  • 30 Seidman S. Exploring the relationship between depression and erectile dysfunction in aging men. J Clin Psychiatry 2002; 63 (05) 5-12
    PubMedGoogle Scholar
  • 31 Barkin J. Erectile dysfunction and hypogonadism (low testosterone). Can J Urol 2011; 18 (April, Suppl) 2-7
    PubMedGoogle Scholar
  • 32 Gurbuz N, Mammadov E, Usta MF. Hypogonadism and erectile dysfunction: an overview. Asian J Androl 2008; 10 (01) 36-43
    CrossrefPubMedGoogle Scholar
  • 33 Shabsigh R. Hypogonadism and erectile dysfunction: the role for testosterone therapy. Int J Impot Res 2003; 15 (Suppl. 04) S9-S13
    CrossrefPubMedGoogle Scholar
  • 34 Collazos J. Sexual dysfunction in the highly active antiretroviral therapy era. AIDS Rev 2007;9:237–245
    PubMed